TURNER JOSEPH L 4
4 · Arcutis Biotherapeutics, Inc. · Filed Jun 3, 2022
Insider Transaction Report
Form 4
TURNER JOSEPH L
Director
Transactions
- Award
Common Stock
2022-06-01+4,312→ 4,312 total - Award
Stock Option (Right to Buy)
2022-06-01+11,796→ 11,796 totalExercise: $20.29Exp: 2032-06-01→ Common Stock (11,796 underlying)
Footnotes (2)
- [F1]Includes 4,312 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.
- [F2]The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of June 1, 2022.